Aditxt Announces the Successful Passage of all Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic PlansAditxt (NASDAQ: ADTX) announced the successful passage of all nine proposals at its recent annual shareholders' meeting, setting the stage for its 2024 and 2025 strategic plans. Key approvals include:
1. Election of directors
2. Ratification of auditors
3. Issuance of shares for Series B-1 and B-2 Convertible Preferred Stock
4. Equity Line of Credit (ELOC) proposal for up to $150 million
5. Increase in authorized shares from 100 million to 1 billion
6. Reverse stock split authority (1:5 to 1:200)
7. Amendment to the 2021 Omnibus Equity Incentive Plan
These approvals provide Aditxt with flexibility and potential resources to advance its strategic initiatives in immune health, precision health, public health, and women's health programs.
amiable Hedgehog_758 : when the stock gonna R.S